EZH2 also maintains MHC-I epigenetic silencing in a subset of solid tumors including small cell lung cancer, neuroblastoma and Merkel cell carcinoma [43]; EZH2 inhibition restored MHC-I expression in lung cancer via NLRC5 and IRF1 de-repression [43]. This evidence concerns the gene EZH2 and Merkel cell skin cancer.